3,929 Shares in Avanos Medical Inc (AVNS) Purchased by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. bought a new stake in Avanos Medical Inc (NYSE:AVNS) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 3,929 shares of the company’s stock, valued at approximately $269,000.

Several other hedge funds also recently bought and sold shares of the company. Wells Fargo & Company MN purchased a new stake in shares of Avanos Medical during the third quarter valued at approximately $66,612,000. Victory Capital Management Inc. purchased a new stake in shares of Avanos Medical during the third quarter valued at approximately $63,892,000. Chicago Equity Partners LLC purchased a new stake in shares of Avanos Medical during the third quarter valued at approximately $10,258,000. Moody Aldrich Partners LLC purchased a new stake in shares of Avanos Medical during the third quarter valued at approximately $5,702,000. Finally, Retirement Systems of Alabama purchased a new stake in shares of Avanos Medical during the third quarter valued at approximately $4,186,000. Institutional investors own 84.10% of the company’s stock.

NYSE:AVNS opened at $49.66 on Thursday. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.78 and a quick ratio of 2.18. Avanos Medical Inc has a 1 year low of $43.78 and a 1 year high of $72.96. The firm has a market capitalization of $2.31 billion, a price-to-earnings ratio of 21.13 and a beta of 1.86.

Avanos Medical (NYSE:AVNS) last released its earnings results on Tuesday, November 6th. The company reported $0.37 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.28 by $0.09. Avanos Medical had a return on equity of 6.59% and a net margin of 14.26%. The business had revenue of $165.10 million during the quarter, compared to the consensus estimate of $166.57 million. The firm’s quarterly revenue was up 9.7% compared to the same quarter last year. On average, equities research analysts predict that Avanos Medical Inc will post 1.87 EPS for the current fiscal year.

A number of brokerages recently commented on AVNS. Zacks Investment Research downgraded Avanos Medical from a “hold” rating to a “sell” rating in a research report on Wednesday. Barclays began coverage on Avanos Medical in a research report on Monday, October 15th. They set an “equal weight” rating and a $69.00 price target for the company. Morgan Stanley increased their price target on Avanos Medical from $60.00 to $62.00 and gave the company an “underweight” rating in a research report on Thursday, October 11th. KeyCorp increased their price target on Avanos Medical from $66.00 to $75.00 and gave the company an “overweight” rating in a research report on Wednesday, August 8th. Finally, Raymond James raised Avanos Medical from a “market perform” rating to an “outperform” rating in a research report on Tuesday, August 21st. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the company’s stock. Avanos Medical presently has a consensus rating of “Hold” and a consensus target price of $69.25.

TRADEMARK VIOLATION NOTICE: This piece was posted by WKRB News and is owned by of WKRB News. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of international trademark and copyright law. The correct version of this piece can be accessed at https://www.wkrb13.com/2018/11/09/3929-shares-in-avanos-medical-inc-avns-purchased-by-rockefeller-capital-management-l-p.html.

Avanos Medical Company Profile

Avanos Medical, Inc operates as a medical technology company that focuses on eliminating pain, speeding recovery, and preventing infection for healthcare providers and patients worldwide. Its Medical Devices segment provides a portfolio of products that focuses on respiratory and digestive health, along with surgical and interventional pain management.

Read More: How is the S&P 500 index different from the DJIA?

Want to see what other hedge funds are holding AVNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avanos Medical Inc (NYSE:AVNS).

Institutional Ownership by Quarter for Avanos Medical (NYSE:AVNS)

Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply